DAO and schizophrenia: As hypofunction of the NMDAR-mediated signaling pathway has been considered a molecular mechanism underlying schizophrenia [32], studies have shown reduced levels of D-serine in the cerebrospinal fluid and serum [33,34,35,36] and increased protein levels and activities of DAAO in patients with schizophrenia [35,37,38].